|
|
|
|
|
|
|
|
CONCLUSIONS
Although individual studies have not yet convincingly shown a survival advantage with maintenance chemotherapy in OC, this meta-analysis demonstrates that continued chemotherapy after completion of primary therapy for OC improves PFS and OS. Benefits are greatest in patients with advanced stage OC who reach complete clinical or pathologic response after primary therapy.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.